The objective of a study titled “Neonatal Abstinence Syndrome After in Utero Exposure to Selective Serotonin Reuptake inhibitors in Term Infants”, written by researchers from the Neonatal Intensive Care Unit at Schneider Children’s Medical Center of Israel, led by R. Levinson-Castiel was to determine the prevalence and clinical characteristics of neonatal abstinence syndrome

The objective of a study done titled “Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study” by  LH. Pedersen from the Department of Epidemiology, Institute of Public Health, Aarhus University, was to take a closer look between selective serotonin reuptake inhibitors taken during pregnancy and their ability to cause

A study conducted by the Department of Psychological Medicine, King Edward Memorial Hospital for Women, Subiaco, Australia, titled “Placental Transfer of SSRI and SNRI Antidepressants and Effects On The Neonate”, investigated placental transfer and neurobehavioural effects in neonates exposed to venlafaxine (Effexor), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine, fluoxetine (Prozac), escitalopram, and citalopram (Celexa).  

The objective of a study published by researchers from the OMNI Research Group within the Department of Obstetrics and Gynaecology at The University of Ottawa, in Ottawa ON, titled “The Use of Selective Serotonin Reuptake Inhibitors in Pregnancy”, was to update literature on the safety of using selective serotonin reuptake inhibitors during pregnancy.

Published in a 2005 edition of the Journal of the American Medical Association, a study by Dr. Eydie L. Moses-Kolko et al., titled “Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors,” reviews the danger posed to infants whose mothers used serotonin reuptake inhibitors (SRIs), a new type of antidepressant and

A 2006 study from Denmark, published in the medical journal Epidemiology, has evaluated the risk for birth defects and other neonatal complications that results from maternal use of SSRI drugs during pregnancy.  “SSRI” stands for selective serotonin reuptake inhibitor and represents a new class of antidepressant drugs that change levels of serotonin in the

Spina Bifida (“myelomeningocele” being the most common form) is a birth defect in the larger class of “neural tube defects,” characterized by the malformation or underdevelopment of the neural tube in a developing infant before birth.  In spina bifida, “the backbone and spinal canal do not close before birth”[1] as they normally would.

PubMed

Anal atresia, or “imperforate anus,” is a congenital birth defect “in which the opening to the anus is missing or blocked.”[1]  PubMed Health, a prominent online medical encyclopedia curated by the U.S. National Library of Medicine, states that anal atresia may manifest in several different ways:

  • “The rectum may end in a blind pouch

Omphalocele is a congenital birth defect in which the intestines or other abdominal organs stick out of the baby’s navel, and is considered a type of hernia.  Babies born with omphalocele are at a dramatically increased risk for intestinal infection,[1] and “death of intestinal tissue,”[2] both of which are very serious medical conditions

Limb reduction deficits are congenital (from birth) malformations of the newborn’s body in which one or more of the limbs does not fully develop, either partially or fully, before birth.[1]  The United States Centers for Disease Control and Prevention (CDC) reports that in the general population, about 4 babies in every 10,000 are born